Review



hdl cholesterol  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Thermo Fisher hdl cholesterol
    Hdl Cholesterol, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/snp+microarray+analysis+high-density+snp+array/Cholesterol/pm29861390-194-93-119
    Average 99 stars, based on 1 article reviews
    hdl cholesterol - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Amplex Red Cholesterol Assay:

    Article Title: Pseudouridylation of rRNA by specific snoRNA disrupts ribosomal machinery and consequently affects metabolism, longevity and neurodegeneration
    Article Snippet: .. Free sterol and sterol-ester levels were measured using the Amplex Red cholesterol assay kit ( Invitrogen , Cat. #A12216), according to the manufacturer’s instructions. ..

    Article Title: An environmentally relevant mixture of organophosphate esters induces cholesterol biosynthesis in THP-1 macrophages.
    Article Snippet: .. 2.7 Evaluation of cellular cholesterol 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 D ow nloaded from https://academ ic.oup.com /toxsci/advance-article/doi/10.1093/toxsci/kfag048/8660478 by guest on 24 April 2026 11 Total cholesterol in THP-1 macrophages was measured using an AMPLEX red cholesterol assay kit (Thermofisher Scientific, #A12216). ..

    Biomarker Discovery:

    Article Title: Effects of PCSK9 inhibitors on vascular function, lipid profile, and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis
    Article Snippet: .. Clavijoa, 2023 , RCT, Double-blind , USA , 6 months , Evolocumab 420 mg SC q4w , placebo , 35 , 35 , 70 , Patients aged 40–85 years with a diagnosis of atherosclerotic cardiovascular disease and PAD (Rutherford class I-VI), confirmed by an ankle-brachial index (ABI) ≤0.9 at rest or ≤0.8 after exercise, angiography, duplex ultrasound, or a history of lower extremity surgical or endovascular revascularization. Patients had to be at least one month from their most recent intervention, stable on maximal tolerated lipid-lowering therapy for at least four weeks, and have a fasting LDL cholesterol ≥55 mg/dL or non-HDL cholesterol ≥80 mg/dL. , MWT at 6 months , After six months, Evolocumab significantly improved MWT, FMD, Carotid IMT, and plasma MRP-14 levels. In contrast, changes in pain-free walking time, ABI, TBI, transcutaneous oxygen pressure, oxLDL, and sCD36 were not statistically significant.. .. Sato, 2020 , PO, Single center , Japan , 18 ± 11 months , Evolocumab, 140 mg SC q2w or 420 mg, SC q4w , placebo , 14 , 16 , 30 , Patients with CLTI were eligible if they had either ischemic foot rest pain with ABI <0.4, ankle pressure <50 mmHg, toe pressure <30 mmHg, or SPP <30 mmHg, or if they presented with a foot ulcer or gangrene accompanied by significant PAD. Those considered for evolocumab had to be on high-intensity statin therapy, have at least one major cardiovascular risk factor (such as CAD, stroke, CKD, or diabetes), and an LDL-C level ≥70 mg/dL , 12-month freedom from major amputation , After 12 months, evolocumab significantly improved amputation-free survival, wound-free limb salvage, and lipid parameters (LDL-C, non-HDL-C, MDA-LDL). Conversely, changes in freedom from major amputation, overall survival, and ABI were not statistically significant..

    Clinical Proteomics:

    Article Title: Effects of PCSK9 inhibitors on vascular function, lipid profile, and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis
    Article Snippet: .. Clavijoa, 2023 , RCT, Double-blind , USA , 6 months , Evolocumab 420 mg SC q4w , placebo , 35 , 35 , 70 , Patients aged 40–85 years with a diagnosis of atherosclerotic cardiovascular disease and PAD (Rutherford class I-VI), confirmed by an ankle-brachial index (ABI) ≤0.9 at rest or ≤0.8 after exercise, angiography, duplex ultrasound, or a history of lower extremity surgical or endovascular revascularization. Patients had to be at least one month from their most recent intervention, stable on maximal tolerated lipid-lowering therapy for at least four weeks, and have a fasting LDL cholesterol ≥55 mg/dL or non-HDL cholesterol ≥80 mg/dL. , MWT at 6 months , After six months, Evolocumab significantly improved MWT, FMD, Carotid IMT, and plasma MRP-14 levels. In contrast, changes in pain-free walking time, ABI, TBI, transcutaneous oxygen pressure, oxLDL, and sCD36 were not statistically significant.. .. Sato, 2020 , PO, Single center , Japan , 18 ± 11 months , Evolocumab, 140 mg SC q2w or 420 mg, SC q4w , placebo , 14 , 16 , 30 , Patients with CLTI were eligible if they had either ischemic foot rest pain with ABI <0.4, ankle pressure <50 mmHg, toe pressure <30 mmHg, or SPP <30 mmHg, or if they presented with a foot ulcer or gangrene accompanied by significant PAD. Those considered for evolocumab had to be on high-intensity statin therapy, have at least one major cardiovascular risk factor (such as CAD, stroke, CKD, or diabetes), and an LDL-C level ≥70 mg/dL , 12-month freedom from major amputation , After 12 months, evolocumab significantly improved amputation-free survival, wound-free limb salvage, and lipid parameters (LDL-C, non-HDL-C, MDA-LDL). Conversely, changes in freedom from major amputation, overall survival, and ABI were not statistically significant..

    Article Title: Cell type-specific control of cardiometabolic disease by the dileucine motif of the LDL receptor-related protein LRP1
    Article Snippet: .. Plasma obtained from animals after an overnight fast was used to quantify plasma cholesterol and triglyceride levels using Infinity colorimetric assay kits (TR22421 and TR13421, Thermo Fisher Scientific). ..

    Article Title: Centrifuge-free separation of plasma from milliliters of whole blood for point-of-care diagnostics.
    Article Snippet: .. Total cholesterol was measured using the Total Cholesterol Colorimetric Assay kit (EEA026, Invitrogen) on undiluted plasma. ..

    Colorimetric Assay:

    Article Title: Cell type-specific control of cardiometabolic disease by the dileucine motif of the LDL receptor-related protein LRP1
    Article Snippet: .. Plasma obtained from animals after an overnight fast was used to quantify plasma cholesterol and triglyceride levels using Infinity colorimetric assay kits (TR22421 and TR13421, Thermo Fisher Scientific). ..

    Article Title: Centrifuge-free separation of plasma from milliliters of whole blood for point-of-care diagnostics.
    Article Snippet: .. Total cholesterol was measured using the Total Cholesterol Colorimetric Assay kit (EEA026, Invitrogen) on undiluted plasma. ..

    other:

    Article Title: Inhibiting AIDA suppresses VSMC-derived foam cell formation and atherosclerosis by hindering CD36 membrane translocation.
    Article Snippet: Dil-labeled oxidized LDL (Dil-oxLDL, 20 μg/mL; 20609ES76; Yeasen Biotechnology, China) was added to MOVAS cells to assess cellular cholesterol uptake capacity.

    Article Title: Tuning the Composition of Spherical High-Density Lipoprotein-Like Nanoparticles Modulates in Vitro Function
    Article Snippet: Samples were diluted 5-fold in 1X Reaction Buffer prior to quantification using the Amplex Red Cholesterol Assay (ThermoFisher; Waltham, MA), following the manufacturer’s instructions.



    Similar Products

    snp microarray analysis high-density snp array  (Thermo Fisher)
    90
    Thermo Fisher snp microarray analysis high-density snp array
    Snp Microarray Analysis High Density Snp Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/snp+microarray+analysis+high-density+snp+array/pmc03226941-56-0-13
    Average 90 stars, based on 1 article reviews
    snp microarray analysis high-density snp array - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results